| Literature DB >> 28428224 |
Huichun Xu1, Kathleen A Ryan1, Thomas J Jaworek1, Lorraine Southam2,3, Jeffrey G Reid4, John D Overton4, Aris Baras4, Marja K Puurunen4, Eleftheria Zeggini3, Simeon I Taylor1, Alan R Shuldiner4, Braxton D Mitchell5,6.
Abstract
Alleles associated with lower levels of LDL cholesterol (LDL-C) have recently been associated with an increased risk of type 2 diabetes (T2D), highlighting the complex relationship between LDL-C and diabetes. This observation begs the question of whether LDL-C-raising alleles are associated with a decreased risk of T2D. This issue was recently addressed in a large familial hypercholesterolemia (FH) screening study, which reported a lower prevalence of self-reported diabetes in FH subjects than in age-matched relatives without FH. To extend this observation, we tested the association of FH with diabetes status and glycemia in a large Amish population enriched for the FH-associated APOB R3527Q variant that included 640 APOB R3527Q carriers and 4,683 noncarriers. Each copy of the R3527Q T allele was associated with a 74.9 mg/dL increase in LDL-C. There was little difference in T2D prevalence between subjects with (5.2%) and without (4.5%) the R3527Q allele (P = 0.23), and there was no association between R3527Q variant and impaired fasting glucose, fasting glucose or insulin, or oral glucose tolerance test-derived measures. Our data provide no evidence supporting an association between the APOB R3527Q variant and T2D or glycemia and highlight the asymmetry of the LDL-C-T2D relationship and/or the gene/variant-dependent specificity of the LDL-C-T2D association.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28428224 PMCID: PMC5482078 DOI: 10.2337/db17-0173
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461